1-7 of 7
Natsumi Irahara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Free
Shuji Ogino, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, III, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs, for the Cancer and Leukemia Group B, North Central Cancer Treatment Group, Canadian Cancer Society Research Institute, Southwest Oncology Group
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7322–7329.
https://doi.org/10.1158/1078-0432.CCR-09-1570
Published: 30 November 2009
View article titled, KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
Open the PDF for KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 in another window
Journal Articles

Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

Free
Shuji Ogino, Katsuhiko Nosho, Natsumi Irahara, Jeffrey A. Meyerhardt, Yoshifumi Baba, Kaori Shima, Jonathan N. Glickman, Cristina R. Ferrone, Mari Mino-Kenudson, Noriko Tanaka, Glenn Dranoff, Edward L. Giovannucci, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (20): 6412–6420.
https://doi.org/10.1158/1078-0432.CCR-09-1438
Published: 14 October 2009
View article titled, Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
Open the PDF for Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype in another window
Includes: Supplementary data
Journal Articles

Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer

Free
Yoshifumi Baba, Katsuhiko Nosho, Kaori Shima, Ellen Freed, Natsumi Irahara, Juliet Philips, Jeffrey A. Meyerhardt, Jason L. Hornick, Ramesh A. Shivdasani, Charles S. Fuchs, Shuji Ogino
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4665–4673.
https://doi.org/10.1158/1078-0432.CCR-09-0401
Published: 15 July 2009
View article titled, Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer
Open the PDF for Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer in another window
Journal Articles

A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases

Free
Shuji Ogino, Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Yoshifumi Baba, Saori Toyoda, Li Chen, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4431–4438.
https://doi.org/10.1158/1078-0432.CCR-08-3330
Published: 01 July 2009
View article titled, A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases
Open the PDF for A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases in another window
Includes: Supplementary data
Journal Articles

DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer

Free
Katsuhiko Nosho, Kaori Shima, Natsumi Irahara, Shoko Kure, Yoshifumi Baba, Gregory J. Kirkner, Li Chen, Sumita Gokhale, Aditi Hazra, Donna Spiegelman, Edward L. Giovannucci, Rudolf Jaenisch, Charles S. Fuchs, Shuji Ogino
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3663–3671.
https://doi.org/10.1158/1078-0432.CCR-08-2383
Published: 01 June 2009
View article titled, DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Open the PDF for DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer

Free
Shuji Ogino, Gregory J. Kirkner, Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Aditi Hazra, Andrew T. Chan, Reiko Dehari, Edward L. Giovannucci, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8221–8227.
https://doi.org/10.1158/1078-0432.CCR-08-1841
Published: 15 December 2008
View article titled, Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Open the PDF for Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer in another window
Journal Articles

Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers

Free
Yuri Takahashi, Yasuo Miyoshi, Chie Takahata, Natsumi Irahara, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1380–1385.
https://doi.org/10.1158/1078-0432.CCR-04-1773
Published: 02 March 2005
View article titled, Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers
Open the PDF for Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers in another window